Bill · H.R. 5629· House(119-HR-5629)
To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
- Introduced
- 9/30/2025
- Last activity
- 9/30/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Erin Houchin
- Cosponsors
- None
- Introduced
- In Committee
What this bill would do
This bill aims to nullify a specific final rule issued by the Department of Health and Human Services. The rule in question is titled "Medications for the Treatment of Opioid Use Disorder." This legislation would ensure that the rule has no force or effect. However, there is one specific exception included in the text. The portion of the rule relating to the accreditation of opioid treatment programs would remain in effect.
Yes
No question was scored yes.
The opposite· 3 of 4
Does this do more about addiction and overdose deaths?-5
The bill nullifies a Department of Health and Human Services final rule specifically designed to regulate medications for the treatment of opioid use disorder.
Would households on low incomes be better off under this?-3
The removal of regulations on medications for opioid use disorder may negatively affect low-income individuals seeking treatment.
Does this give the federal government more power?-3
The bill reduces the regulatory authority of a federal agency by nullifying its final rule regarding opioid treatment medications.
Who it would affect, and how
Potential Positive Impacts for People
- Nullification of the HHS Final Rule: By providing that the rule titled "Medications for the Treatment of Opioid Use Disorder" has no force or effect, the bill changes the current regulatory landscape regarding these medications. (Section 1(a))
Potential Negative Impacts for People
- Removal of the HHS Final Rule: The bill would strip the force and effect of the Department of Health and Human Services' final rule regarding medications for the treatment of opioid use disorder, with the exception of accreditation modifications. (Section 1(a))
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Low Income Households-3Good For People With Disabilities-2
- Healthcare
- Improves Opioid Crisis Response-5
- Governance And Ideology
- Increases Federal Power-3
- 9/30/2025
- Referred to the House Committee on Energy and Commerce.
- Introduced in House